3,693
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Ezetimibe in diabetes: more than cholesterol lowering?

, &
Pages 2517-2520 | Accepted 23 Aug 2010, Published online: 15 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Rabia Nabi, Sahir Sultan Alvi, Arunim Shah, Chandra P. Chaturvedi, Mohammad Faisal, Abdulrahman A. Alatar, Saheem Ahmad & M. Salman Khan. (2023) Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats. Archives of Physiology and Biochemistry 129:4, pages 831-846.
Read now
Niki Katsiki, Dimitri P Mikhailidis & Maciej Banach. (2019) Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease. Expert Opinion on Pharmacotherapy 20:16, pages 2007-2017.
Read now
Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez & Dimitri P. Mikhailidis. (2018) Dyslipidaemia in the elderly: to treat or not to treat?. Expert Review of Clinical Pharmacology 11:3, pages 259-278.
Read now
Niki Katsiki, Vasilis G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2011) Ezetimibe and low density lipoprotein subfractions: an ongoing debate. Current Medical Research and Opinion 27:3, pages 693-695.
Read now

Articles from other publishers (9)

Galal Magdy, Amira A. Al-enna, Fathalla Belal, Ramadan A. El-Domany & Ahmed M. Abdel-Megied. (2023) Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage forms. BMC Chemistry 17:1.
Crossref
Kuo Yang, Yuxia Yang, Shuyue Fan, Jianan Xia, Qiguang Zheng, Xin Dong, Jun Liu, Qiong Liu, Lei Lei, Yingying Zhang, Bing Li, Zhuye Gao, Runshun Zhang, Baoyan Liu, Zhong Wang & Xuezhong Zhou. (2023) DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning. Briefings in Bioinformatics 24:1.
Crossref
Djordje S. Popovic, Stella Papachristou, Edita Stokic & Nikolaos Papanas. (2022) Ezetimibe and Insulin Resistance. Current Vascular Pharmacology 20:4, pages 315-317.
Crossref
Kadir Uğur Mert, Özcan Başaran, Gurbet Özge Mert, Volkan Doğan, İbrahim Rencüzoğulları, Bülent Özlek, Göksel Cinier, Utku Şenol, Oğuzhan Çelik, Eda Özlek, İbrahim Halil Özdemir, Fatma Özpamuk Karadeniz, Lütfü Bekar, Müjdat Aktaş, Mübariz Murat Resulzade, Macit Kalçık, Gökhan Aksan, Kadriye Akay, Nihat Pekel, Murat Biteker & Meral Kayıkçıoğlu. (2021) Management of LDL‐cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real‐life evidence of Under‐treatment from the EPHESUS registry. European Journal of Clinical Investigation 51:7.
Crossref
Ioanna Zografou, Fotios Iliadis, Christos Sambanis & Triantafyllos Didangelos. (2020) Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement. Current Vascular Pharmacology 18:5, pages 517-522.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 285 315 .
Seigo Sugiyama, Hideaki Jinnouchi, Kunio Hieshima, Noboru Kurinami, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara, Kunihiko Matsui & Tomio Jinnouchi. (2015) A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus. Lipids in Health and Disease 14:1.
Crossref
Shang-Hung Chang, Lung-Sheng Wu, Cheng-Hung Lee, Chi-Tai Kuo, Jia-Rou Liu, Ming-Shien Wen, Wei-Jan Chen, Lai-Chu See & Yung-Hsin Yeh. (2015) Simvastatin–ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study. International Journal of Cardiology 190, pages 20-25.
Crossref
George N. Kouvelos, Eleni M. Arnaoutoglou, Haralampos J. Milionis, Vaia D. Raikou, Nektario Papa & Miltiadis I. Matsagkas. (2014) The Effect of Adding Ezetimibe to Rosuvastatin on Renal Function in Patients Undergoing Elective Vascular Surgery. Angiology 66:2, pages 128-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.